HIV Prevention and Program Science: Analysis and Policy Research

Overview

Conducted research and analysis supporting HIV program science and prevention strategy, including epidemiological analysis of HIV incidence trends, analytical reviews of prevention interventions, and mathematical modeling of program impact. This work supported global health partners in understanding HIV transmission dynamics and strengthening prevention programs across multiple regions.

Role

Research analyst supporting the Director of the World Bank Global HIV/AIDS Program, coordinating modeling studies and conducting analytical research and evidence synthesis on HIV epidemiology and prevention strategy.

Key Contributions & Outputs

• Conducted epidemiological analysis of HIV incidence trends and analytical reviews of HIV prevention strategies, synthesizing empirical and modeled evidence on transmission dynamics and the effectiveness of biomedical, social, and structural interventions

• Authored a chapter in the Disease Control Priorities series on HIV program science, examining how national HIV responses can be tailored to local epidemic contexts

• Managed multi-country mathematical modeling studies of HIV incidence and program impact across Africa, Latin America, and the Caribbean, coordinating collaboration among multilateral, government, and academic partners

• Translated research findings into peer-reviewed publications, policy reports, and presentations for government, NGO, and civil society stakeholders

DCP3 Chapter on HIV Program Science: Tailoring the Local HIV/AIDS Response to Local HIV/AIDS Epidemics

Development Policy Review: The impact of cash transfers on livelihoods, education, health and HIV – what's the evidence?

World Bank Policy Research Working Paper: A Comprehensive Review of Empirical and Modeled HIV Incidence Trends (1990-2012)

Impact

This work informed global discussions on HIV prevention strategy, including how epidemiological evidence, modeling, and program science can inform more effective and locally tailored HIV responses.

Previous
Previous

This Week in Global Health: Scientific Communication

Next
Next

Next-Generation Influenza Vaccine R&D Landscape: Analysis